Prosecution Insights
Prosecution Insights
6 pending office actions • 1 client • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| No statute on record | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LIU, TRACY | 1 | 54.9% | +28.0% |
| BERKE-SCHLESSEL, DAVID W | 1 | 66.5% | +32.1% |
| LEITH, NANCY J | 1 | 74.7% | +43.8% |
| SMALL, KATHERINE R | 1 | 65.4% | +29.7% |
| MIANO, JOSEPH PAUL | 1 | 37.9% | +63.3% |
| RIGA, MICHAEL ANGELO | 1 | 51.8% | +63.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18004403 | METHODS AND COMPOSITIONS FOR PRODUCING VIRAL FUSOSOMES | BERKE-SCHLESSEL, DAVID W | 42d overdue |
| 16970216 | COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY | RIGA, MICHAEL ANGELO | 28d overdue |
| 17055077 | FUSOSOME COMPOSITIONS AND USES THEREOF | MIANO, JOSEPH PAUL | 15d overdue |
| 17293802 | FUSOSOME COMPOSITIONS FOR T CELL DELIVERY | LEITH, NANCY J | 11d overdue |
| 18154618 | COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF | LIU, TRACY | 5d |
| 17293797 | FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY | SMALL, KATHERINE R | 57d |
| Client (Assignee) | Pending OAs |
|---|---|
| Flagship Pioneering | 6 |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
| 1651 | 1 |
| 1636 | 1 |
| 1633 | 1 |
| 1631 | 1 |
| 1634 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18154618 | COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF | Flagship Pioneering Innovations V, Inc. | LIU, TRACY | 1614 | §103 | Final Rejection | 5d | Pending | Jan 13, 2023 |
| 18004403 | METHODS AND COMPOSITIONS FOR PRODUCING VIRAL FUSOSOMES | Flagship Pioneering Innovations V, Inc. | BERKE-SCHLESSEL, DAVID W | 1651 | Other | Final Rejection | 42d overdue | Pending | Jan 05, 2023 |
| 17293802 | FUSOSOME COMPOSITIONS FOR T CELL DELIVERY | Flagship Pioneering Innovations V, Inc. | LEITH, NANCY J | 1636 | §103 | Final Rejection | 11d overdue | Pending | May 13, 2021 |
| 17293797 | FUSOSOME COMPOSITIONS FOR HEMATOPOIETIC STEM CELL DELIVERY | Flagship Pioneering Innovations V, Inc. | SMALL, KATHERINE R | 1633 | §103 | Final Rejection | 57d | Pending | May 13, 2021 |
| 17055077 | FUSOSOME COMPOSITIONS AND USES THEREOF | Flagship Pioneering Innovations V, Inc. | MIANO, JOSEPH PAUL | 1631 | Other | Non-Final OA | 15d overdue | Pending | Nov 12, 2020 |
| 16970216 | COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY | Flagship Pioneering Innovations V, Inc. | RIGA, MICHAEL ANGELO | 1634 | §103 | Non-Final OA | 28d overdue | Pending | Aug 14, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial